ENS-CCA/Precision-BTC-Network Joint Conference

June 11-12, 2026

 

Rodos Palace Hotel

The annual meeting of the COST Action PRECISION-BTC-NETWORK — held jointly with the biennial ENS-CCA conference — promises a dynamic and forward-looking program focused on advancing the field of biliary tract cancers and fostering high-impact collaborations.

The first day of this two day event will be dedicated to Academia–Pharma interaction — a space to strengthen partnerships, share insights, and explore translational opportunities.

The second day will be focused on collaborative projects from our diverse Working Groups — showcasing the power of teamwork across borders and disciplines.

Registration is open! Deadline for registration is May 6th. 

Precision-BTC-Network Management Committee Meeting

June 22, 2026

 

Online

This meeting is open exclusively to Precision-BTC-Network Management Committee (MC) members.

AMMF 2026 European Cholangiocarcinoma Conference

May 13-15, 2026

AMMF’s annual conference is a unique and invaluable educational opportunity for all healthcare professionals and researchers with an interest in cholangiocarcinoma. As always, 2026 will include dedicated sessions for patients, carers, families and friends, too.

Each year, AMMF aims to deliver a world-leading event – and 2026 is no exception. For this conference, the multi-disciplinary specialist group Cholangiocarcinoma-UK* is partnering with AMMF to highlight the latest progress in the rapidly evolving treatment landscape for cholangiocarcinoma.

AMMF is delighted to have international co-chairs Professor Brian Davidson (UK) and Dr Angela Lamarca (Spain; Precision-BTC-Network WG3 co-Leader/Management Committee) to lead a distinguished global faculty, as together they explore the 2026 theme, Shaping the future: from early detection to improved survival.

ENS-CCA/Precision-BTC-Network Joint Conferenece

July 1-2, 2024

 

Jagiellonian University, Didactic Centre of the Faculty of Law and Administration

The annual meeting of the COST Action PRECISION-BTC-NETWORK (Management Committee and General Meeting) to be held jointly with the binnnial ENS-CCA conference.

This meeting will focus on biliary tract cancer, covering a wide range of topics including adjuvant treatment, immunotherapy, biomarkers for patients’ selection, the role of artificial intelligence in guiding treatment choice, discussion of the data from the large international European registry on bile duct cancers, development of novel therapeutics with a focus on targeting the microenvironment and the immune system. 

SUMMARY

Action Meeting & Liquid Biopsy Monothematic Conference

May 22-23, 2025

 

Hotel Palma Bellver

The Monothematic Conference Liquid Biopsy in BTC: from bench to bedside will be held jointly with the annual meeting of the COST Action Precision-BTC Network (Management Committee and General Meeting). This meeting will focus on biliary tract cancer, with a major aim to consolidate current knowledge and to draw a roadmap towards the adoption of liquid biopsy as a key tool in the diagnosis and personalized treatment of biliary tumors. Additionally, the conference aims to discuss the latest findings related to epidemiology, new therapies, artificial intelligence and preclinical models for the development of new drugs for patients with biliary tumors.

SUMMARY

AMMF 2025 European Cholangiocarcinoma Conference

May 7-9, 2025

The theme for this year's conference is: 'Cholangiocarcinoma: A Fairer Deal, Faster – RETHINKING LIVER CANCER'. 

The conference will focus on tackling health inequalities in cholangiocarcinoma diagnosis and treatment, building on insights from AMMF’s data project. An international faculty of some 40 speakers will discuss key challenges in earlier diagnosis, multi-disciplinary assessments, and specialist referrals, all of which influence patient outcomes.

Click the links below for a recording of this conference & for more information!

12th Annual Cholangiocarcinoma Foundation Conference

April 9-11, 2025

The event is a unique opportunity for patients and caregivers to join leading experts in shaping the future of cholangiocarcinoma research. The initiative brings together patients, caregivers, advocates, oncologists, scientists, industry representatives, regulators, and other specialists worldwide to review scientific evidence, share insights, and reach a consensus on the research focus going forward to optimize existing funding and attract new funding.

This year’s Conference is an effort between CCF’s International Cholangiocarcinoma Research Network (ICRN) and the European Cooperation in Science and Technology (COST)-Action: Precision-BTC-Network.

13th Annual Cholangiocarcinoma Foundation Conference

May 1-3, 2026

The 13th Annual Cholangiocarcinoma Foundation Conference convenes leading researchers, clinicians, patients, caregivers, and advocates to explore the latest advancements in cholangiocarcinoma and foster collaboration across the community. This year’s conference also celebrates CCF’s 20th anniversary, making it a particularly special gathering.

Conference Chairs: Luke Boulter (Boulter-Lab, University of Edinburgh; Precision-BTC-Network WG6 co-Leader/Management Committee) & Tim F. Greten (Co-Director, NCI CCR Liver Cancer Program)